All the news Showing 10 of 63 articles from: FranceGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C elimination Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline Keith Alcorn / 27 January 2021 Hepatitis C is becoming more concentrated in gay and bisexual men with HIV in France as direct-acting antiviral treatment cures the infection in other people with HIV while hepatitis C transmission between ... Hepatocellular carcinoma (HCC) Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... Treatment for people living with HIV and HCV People with HIV do not have higher liver disease risk after hepatitis C treatment Keith Alcorn / 28 August 2020 People living with HIV do not have a higher risk of liver-related complications or death from liver disease after hepatitis C treatment with direct-acting antivirals, researchers from the French HEPAVIH cohort reported this ... Coronavirus Non-alcoholic fatty liver disease does not raise the risk of COVID-19, gene study shows Keith Alcorn / 26 May 2020 People with a genetic profile that strongly predicts non-alcoholic or metabolic-associated fatty liver disease were not at higher risk of being hospitalised with COVID-19 in the United Kingdom, an analysis of the ... Treatment in acute infection Short-course treatment for recent hepatitis C: some courses may be too short Keith Alcorn / 07 May 2020 An eight-week course of grazoprevir/elbasvir (Zepatier) achieved a high cure rate in people recently infected with hepatitis C, but another study found that a six-week course of sofosbuvir/velpatasvir (Epclusa) resulted in an inferior ... NAFLD Fatty liver raises the risk of death in people with HIV and hepatitis C Keith Alcorn / 15 September 2019 People with HIV and hepatitis C co-infection who had fatty liver disease were twice as likely to die during a five-year follow-up period as their counterparts without fatty liver disease, ... Harm reduction interventions and policy “Marseilles Bears a Heavy Stigma of Drug Trafficking and Use” – An Interview with Beatrice Stambul Drug Reporter / 15 July 2019 Sexual transmission Epidemic of sexually transmitted hepatitis C in gay men now involves both HIV-positive and HIV-negative men Michael Carter / 29 March 2019 Incidence of acute hepatitis C virus (HCV) among men who have sex with men (MSM) who use pre-exposure prophylaxis (PrEP) in Lyon increased tenfold between 2016 and 2017, according to ... Treatment outcomes DAA treatment reduces the risk of death and liver cancer in France Keith Alcorn / 12 February 2019 Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with hepatitis C, according to results of one of the largest studies ... Interferon-Free Hepatitis C Treatments Effective in Elderly Patients Infectious Disease Advisor / 23 January 2019 ← Prev12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive